Management of sustained arrhythmias for patients with cardiogenic shock in intensive cardiac care units.
Action Potentials
Anti-Arrhythmia Agents
/ adverse effects
Arrhythmias, Cardiac
/ diagnosis
Cardiac Resynchronization Therapy
/ adverse effects
Catheter Ablation
/ adverse effects
Coronary Care Units
Heart Rate
Heart-Assist Devices
Humans
Recovery of Function
Risk Factors
Shock, Cardiogenic
/ diagnosis
Treatment Outcome
Ablation par cathéter
Atrial fibrillation
Cardiogenic shock
Catheter ablation
Choc cardiogénique
Electrical storm
Fibrillation atriale
Orage rythmique
Journal
Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
16
03
2019
revised:
30
09
2019
accepted:
02
10
2019
pubmed:
18
11
2019
medline:
19
3
2020
entrez:
18
11
2019
Statut:
ppublish
Résumé
Cardiac arrhythmias that occur in patients referred to intensive care units worsen symptoms and outcomes and need urgent correction, especially in patients admitted for refractory heart failure. Electrical storm is a frequent reason for referral to an intensive care unit. Specific, efficient and rapid management of patients presenting with various arrhythmias is therefore mandatory and procedures should be known by any physician involved in an intensive care unit. This article reviews the current knowledge on the management of supraventricular and ventricular arrhythmias in this setting, from medications and sedation to ablation and more exceptional therapy. It also covers the occasional indications of resynchronization in refractory heart failure and the interest for haemodynamic assistance when specific therapy fails.
Identifiants
pubmed: 31734139
pii: S1875-2136(19)30169-X
doi: 10.1016/j.acvd.2019.10.002
pii:
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
781-791Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.